Low-dose growth hormone inhibits 11 beta-hydroxysteroid dehydrogenase type 1 but has no effect upon fat mass in patients with simple obesity.
GH has potent effects on adipocyte biology, stimulating lipolysis but also promoting preadipocyte proliferation. In addition, GH, acting through IGF-I, inhibits 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1), which converts the inactive glucocorticoid, cortisone (E), to active cortisol (...
主要な著者: | Tomlinson, J, Crabtree, N, Clark, P, Holder, G, Toogood, A, Shackleton, C, Stewart, P |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2003
|
類似資料
-
Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.
著者:: Tomlinson, J, 等
出版事項: (2001) -
Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue.
著者:: Tomlinson, J, 等
出版事項: (2004) -
Cortisol, 11 beta-hydroxysteroid dehydrogenase type 1 and central obesity.
著者:: Stewart, P, 等
出版事項: (2002) -
The functional consequences of 11beta-hydroxysteroid dehydrogenase expression in adipose tissue.
著者:: Tomlinson, J, 等
出版事項: (2002) -
The role of 11 beta-hydroxysteroid dehydrogenase in central obesity and osteoporosis.
著者:: Tomlinson, J, 等
出版事項: (2000)